Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martha C Nason

Showing results (21-30 of 68) with videos related to

Pageof 7
Sort By:
Vaccine|March 30, 2007
Phase I clinical evaluation of a six-plasmid multiclade HIV-1 DNA candidate vaccineAndrew T Catanzaro, Mario Roederer, Richard A Koup, et al.
Blood|March 22, 2007
Keratinocyte growth factor augments immune reconstitution after autologous hematopoietic progenitor cell transplantation in rhesus macaquesRuth Seggewiss, Karin Loré, F Javier Guenaga, et al.
The Journal of Infectious Diseases|January 22, 2011
Plasma levels of soluble CD14 independently predict mortality in HIV infectionNetanya G Sandler, Handan Wand, Annelys Roque, et al.
Nature|April 28, 2016
A single injection of anti-HIV-1 antibodies protects against repeated SHIV challengesRajeev Gautam, Yoshiaki Nishimura, Amarendra Pegu, et al.
Plos One|November 16, 2016
Safety and Immunogenicity of a rAd35-EnvA Prototype HIV-1 Vaccine in Combination with rAd5-EnvA in Healthy Adults (VRC 012)Michelle C Crank, Eleanor M P Wilson, Laura Novik, et al.
Open Forum Infectious Diseases|May 19, 2016
Immunological Signaling During Herpes Simplex Virus-2 and Cytomegalovirus Vaginal Shedding After Initiation of Antiretroviral TreatmentMartha C Nason, Eshan U Patel, Allison R Kirkpatrick, et al.
Clinical Trials (London, England)|January 16, 2016
Implementation of an Ebola virus disease vaccine clinical trial during the Ebola epidemic in Liberia: Design, procedures, and challengesStephen B Kennedy, James D Neaton, H Clifford Lane, et al.
Human Vaccines & Immunotherapeutics|December 9, 2014
Comparison of adaptive and innate immune responses induced by licensed vaccines for Human PapillomavirusDouglas M Herrin, Emily E Coates, Pamela J Costner, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 11, 2019
Prospective International Study of Incidence and Predictors of Immune Reconstitution Inflammatory Syndrome and Death in People Living With Human Immunodeficiency Virus and Severe LymphopeniaIrini Sereti, Virginia Sheikh, Douglas Shaffer, et al.
Immunity|August 5, 2018
Glycan Masking Focuses Immune Responses to the HIV-1 CD4-Binding Site and Enhances Elicitation of VRC01-Class Precursor AntibodiesHongying Duan, Xuejun Chen, Jeffrey C Boyington, et al.
Pageof 7

Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
Vaccine|March 30, 2007
Phase I clinical evaluation of a six-plasmid multiclade HIV-1 DNA candidate vaccineAndrew T Catanzaro, Mario Roederer, Richard A Koup, et al.
Blood|March 22, 2007
Keratinocyte growth factor augments immune reconstitution after autologous hematopoietic progenitor cell transplantation in rhesus macaquesRuth Seggewiss, Karin Loré, F Javier Guenaga, et al.
The Journal of Infectious Diseases|January 22, 2011
Plasma levels of soluble CD14 independently predict mortality in HIV infectionNetanya G Sandler, Handan Wand, Annelys Roque, et al.
Nature|April 28, 2016
A single injection of anti-HIV-1 antibodies protects against repeated SHIV challengesRajeev Gautam, Yoshiaki Nishimura, Amarendra Pegu, et al.
Plos One|November 16, 2016
Safety and Immunogenicity of a rAd35-EnvA Prototype HIV-1 Vaccine in Combination with rAd5-EnvA in Healthy Adults (VRC 012)Michelle C Crank, Eleanor M P Wilson, Laura Novik, et al.
Open Forum Infectious Diseases|May 19, 2016
Immunological Signaling During Herpes Simplex Virus-2 and Cytomegalovirus Vaginal Shedding After Initiation of Antiretroviral TreatmentMartha C Nason, Eshan U Patel, Allison R Kirkpatrick, et al.
Clinical Trials (London, England)|January 16, 2016
Implementation of an Ebola virus disease vaccine clinical trial during the Ebola epidemic in Liberia: Design, procedures, and challengesStephen B Kennedy, James D Neaton, H Clifford Lane, et al.
Human Vaccines & Immunotherapeutics|December 9, 2014
Comparison of adaptive and innate immune responses induced by licensed vaccines for Human PapillomavirusDouglas M Herrin, Emily E Coates, Pamela J Costner, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 11, 2019
Prospective International Study of Incidence and Predictors of Immune Reconstitution Inflammatory Syndrome and Death in People Living With Human Immunodeficiency Virus and Severe LymphopeniaIrini Sereti, Virginia Sheikh, Douglas Shaffer, et al.
Immunity|August 5, 2018
Glycan Masking Focuses Immune Responses to the HIV-1 CD4-Binding Site and Enhances Elicitation of VRC01-Class Precursor AntibodiesHongying Duan, Xuejun Chen, Jeffrey C Boyington, et al.
Pageof 7